Literature DB >> 15995206

A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.

Prabhakar Salunkhe1, Catherine H M Smart, J Alun W Morgan, Stavroula Panagea, Martin J Walshaw, C Anthony Hart, Robert Geffers, Burkhard Tümmler, Craig Winstanley.   

Abstract

The Liverpool epidemic strain (LES) of Pseudomonas aeruginosa is a transmissible aggressive pathogen of cystic fibrosis (CF) patients. We compared transcriptome profiles of two LES isolates with each other and with a laboratory and genetic reference strain (PAO1) after growth to late exponential phase and following exposure to oxidative stress. Both LES isolates exhibited enhanced antimicrobial resistances linked to specific mutations in efflux pump genes. Although transcription of AmpC beta-lactamase was up-regulated in both, one LES isolate contained a specific mutation rendering the ampC gene untranslatable. The virulence-related quorum-sensing (QS) regulon of LES431, an isolate that caused pneumonia in the non-CF parent of a CF patient, was considerably up-regulated in comparison to either isolate LES400, associated with a chronic CF infection, or strain PAO1. Premature activation of QS genes was detected in isolates from both non-CF parents and the CF patient in a previously reported infection episode. LES isolates lacking the up-regulated QS phenotype contained different frameshift mutations in lasR. When fed to Drosophila melanogaster, isolate LES431 killed the fruit flies more readily than either isolate LES400 or strain PAO1, indicating that virulence varies intraclonally. The LES may represent a clone with enhanced virulence and antimicrobial resistance characteristics that can vary or are lost due to mutations during long-term colonization but have contributed to the successful spread of the lineage throughout the CF population of the United Kingdom.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995206      PMCID: PMC1169510          DOI: 10.1128/JB.187.14.4908-4920.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  57 in total

1.  Transcriptional regulation of Pseudomonas aeruginosa rhlR, encoding a quorum-sensing regulatory protein.

Authors:  Gerardo Medina; Katy Juárez; Rafael Díaz; Gloria Soberón-Chávez
Journal:  Microbiology (Reading)       Date:  2003-11       Impact factor: 2.777

2.  Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Authors:  Catherine Llanes; Didier Hocquet; Christelle Vogne; Dounia Benali-Baitich; Catherine Neuwirth; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  Christelle Vogne; Julio Ramos Aires; Christiane Bailly; Didier Hocquet; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

4.  Transcriptome analysis of the response of Pseudomonas aeruginosa to hydrogen peroxide.

Authors:  Marco Palma; Darrow DeLuca; Stefan Worgall; Luis E N Quadri
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

5.  The Pseudomonas aeruginosa RpoS regulon and its relationship to quorum sensing.

Authors:  Martin Schuster; Andrew C Hawkins; Caroline S Harwood; E P Greenberg
Journal:  Mol Microbiol       Date:  2004-02       Impact factor: 3.501

6.  Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.

Authors:  Didier Hocquet; Xavier Bertrand; Thilo Köhler; Daniel Talon; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

7.  Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa.

Authors:  Matthew C Wolfgang; Bridget R Kulasekara; Xiaoyou Liang; Dana Boyd; Kai Wu; Qing Yang; C Garrett Miyada; Stephen Lory
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 11.205

8.  PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa.

Authors:  Stavroula Panagea; Craig Winstanley; Yasmin N Parsons; Martin J Walshaw; Martin J Ledson; C Anthony Hart
Journal:  Mol Diagn       Date:  2003

9.  Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients.

Authors:  M Al-Aloul; J Crawley; C Winstanley; C A Hart; M J Ledson; M J Walshaw
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

10.  Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis.

Authors:  Robert K Ernst; David A D'Argenio; Jeffrey K Ichikawa; M Gita Bangera; Sara Selgrade; Jane L Burns; Peter Hiatt; Karen McCoy; Mitchell Brittnacher; Arnold Kas; David H Spencer; Maynard V Olson; Bonnie W Ramsey; Stephen Lory; Samuel I Miller
Journal:  Environ Microbiol       Date:  2003-12       Impact factor: 5.491

View more
  79 in total

Review 1.  Potential role of chitinases and chitin-binding proteins in host-microbial interactions during the development of intestinal inflammation.

Authors:  H T Tran; N Barnich; E Mizoguchi
Journal:  Histol Histopathol       Date:  2011-11       Impact factor: 2.303

Review 2.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

Review 3.  Cell-cell communication in bacteria: united we stand.

Authors:  Susanne B von Bodman; Joanne M Willey; Stephen P Diggle
Journal:  J Bacteriol       Date:  2008-05-02       Impact factor: 3.490

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.

Authors:  Jeremy R Dettman; Nicolas Rodrigue; Shawn D Aaron; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

6.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

7.  Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models.

Authors:  Erika I Lutter; Monica M P Faria; Harvey R Rabin; Douglas G Storey
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

8.  Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.

Authors:  Holly K Huse; Taejoon Kwon; James E A Zlosnik; David P Speert; Edward M Marcotte; Marvin Whiteley
Journal:  MBio       Date:  2010-09-21       Impact factor: 7.867

9.  Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.

Authors:  Lucas R Hoffman; Anthony R Richardson; Laura S Houston; Hemantha D Kulasekara; Willm Martens-Habbena; Mikkel Klausen; Jane L Burns; David A Stahl; Daniel J Hassett; Ferric C Fang; Samuel I Miller
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

10.  Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7.

Authors:  Paul H Roy; Sasha G Tetu; André Larouche; Liam Elbourne; Simon Tremblay; Qinghu Ren; Robert Dodson; Derek Harkins; Ryan Shay; Kisha Watkins; Yasmin Mahamoud; Ian T Paulsen
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.